Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells

Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells

Objective: Lung cancer is the most common cause of cancer-related deaths worldwide. Platinum-based chemotherapy is one of the main treatment options for patients with non-small cell lung cancer (NSCLC) but the effectiveness of chemotherapy is encumbered by drug resistance. Therefore, understanding t...

Full description

Saved in:
Bibliographic Details
Main Authors: Renjie Chen, Jiahui Wang, Shuoyu Huang, Xuefeng Hu, Xinran He, Tiange Zhang, Yunhan Hu, Huijun Wei, Sihui Nian, Yushu Huang, Zhihao Wu
Format: Article
Language:English
Published: China Anti-Cancer Association 2025-01-01
Series:Cancer Biology & Medicine
Subjects:
cpt1c
chemoresistance
emt
nedd4l
nsclc
Online Access:https://www.cancerbiomed.org/content/22/1/48
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.cancerbiomed.org/content/22/1/48

Similar Items